Trinidad and Tobago

8 Vaccines Approved for Use in Trinidad and Tobago

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: newsday.co.tt
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: newsday.co.tt
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
3 trials in 1 country
Approval Source: health.gov.tt
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
13 trials in 2 countries
Approval Source: newsday.co.tt
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: health.gov.tt
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: news.gov.tt
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: news.gov.tt
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: news.gov.tt